BacTech Appoints Director for Goldco

BacTech Mining Corporation ("BacTech" or the "Company") (TSX VENTURE:BM)
announced that Stephen Fabian has accepted a position as a member of the board
of directors of the company, which will be focused on primary mining projects
subsequent to the separation of BacTech into 2 separate businesses. Mr. Fabian,
a mining engineer, has over 25 years of experience in the mining sector and
related areas including positions with County NatWest in Australia and London.
Mr. Fabian was instrumental in the founding of Ferrous Resources Limited, a
company developing iron ore properties in Brazil. In addition he founded South
American Ferro Metals, an emerging iron ore producer. He is also a principal and
director of the Genus Capital Fund which is now listed on the London Stock
Exchange as the Baker Steel Resource Trust ("BSRT"). BSRT presently holds an 18%
undiluted stake in BacTech.


With the closing of the $2M financing, as set out in the press release dated
August 9, 2010, work can now continue on the Management Information Circular for
the proposed Plan of Arrangement, which will be mailed to shareholders. As part
of the reorganization, it has been decided that the new name for the surviving
entity, currently BacTech Mining Corporation, will be changed to REBgold
Corporation. There will be no change in the number of shares outstanding. 


Finally, the board of directors has approved the issuance of 3,700,000 options
to purchase common shares of the Company to six directors, employees and
consultants of the Company. The exercise price of the options is $0.10. They are
subject to a four-month hold and have a term of 5 years.


The total number of options currently outstanding under the Company's plan is
approximately 8.3% of the outstanding shares.


BACTECH PROFILE

BacTech owns patented bacterial oxidation technology for the treatment of
refractory ores and concentrates to enhance the recovery of gold, silver and
base metals. The Company's initial focus is the acquisition of equity positions
in projects amenable to bioleaching.


Shares outstanding 132,943,039